- Home
- MRNA vs CF Comparison
MRNA vs CF Comparison
Compare MRNA & CF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | CF |
|---|---|---|
| Founded | 2010 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 12.2B |
| IPO Year | 2018 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MRNA | CF |
|---|---|---|
| Price | $31.19 | $77.49 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 15 |
| Target Price | $33.25 | ★ $92.21 |
| AVG Volume (30 Days) | ★ 10.4M | 2.4M |
| Earning Date | 02-13-2026 | 11-05-2025 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | N/A | ★ 31.44 |
| EPS | N/A | ★ 8.27 |
| Revenue | $2,232,000,000.00 | ★ $6,736,000,000.00 |
| Revenue This Year | N/A | $21.14 |
| Revenue Next Year | $2.17 | N/A |
| P/E Ratio | ★ N/A | $9.38 |
| Revenue Growth | N/A | ★ 12.59 |
| 52 Week Low | $22.28 | $67.34 |
| 52 Week High | $48.92 | $104.45 |
Technical Indicators
Market Signals| Indicator | MRNA | CF |
|---|---|---|
| Relative Strength Index (RSI) | 58.27 | 42.52 |
| Support Level | $32.14 | $77.38 |
| Resistance Level | $35.90 | $79.38 |
| Average True Range (ATR) | 1.59 | 1.62 |
| MACD | 0.27 | 0.17 |
| Stochastic Oscillator | 46.75 | 44.36 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CF CF Industries Holdings Inc.
CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making the company one of the lowest-cost nitrogen producers globally. It is also investing in carbon-free blue and green ammonia, which can be used as an alternative fuel to hydrogen or as a means to transport hydrogen.